Compare Innodata Inc (INOD) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Innodata Inc vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Innodata Inc trades at $61.37 (market cap $2.10B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.62 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 12× Innodata Inc's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while Innodata Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Innodata Inc for 19 Days and Royalty Pharma plc Class A Ordinary Shares for 0 Days on average.
| INOD | RPRX | |
|---|---|---|
Market Cap | $2.10B | $25.27B |
Volume | 989,493 | 3,671,183 |
Sector | Technology | Health |
52-Week High | $121.50 | $63.96 |
52-Week Low | $34.45 | $35.44 |
Typical Hold Time | 19 Days | 0 Days |
Enterprise Value | $1.86B | $32.50B |
Dividend Yield | — | 1.66% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Innodata (INOD) trades at $60.80, down 4.12% today amid bearish technical signals. The stock shows strong fundamentals with consistent earnings beats and robust profitability (37.74% ROE, 14.66% net margin). Recent quarterly results exceeded expectations, with Q1 2026 EPS of $0.42 beating estimates by 223%. The company is expanding into motion-capture AI and agentic reinforcement learning, positioning for growth in the AI infrastructure sector.
Despite premium valuations (P/E 47.43), INOD's strong execution and AI market positioning offer upside potential. Key risks include customer concentration and competitive pressures. Analyst consensus is bullish (66.7% buy ratings), though technical indicators suggest near-term caution with the stock trading below key resistance levels.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Innodata Inc
Innodata is a global data engineering company that provides solutions for training AI models. It helps enterprises solve complex data challenges through high-quality data annotation and digital transformation.
Read more on INOD →About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →
